Find information on thousands of medical conditions and prescription drugs.

Q fever

Q fever is a zoonosis caused by the strictly intracellular, gram negative bacterium Coxiella burnetii which proceeds asymptomatic and self-limiting in 60% of the cases. The infectious organism is commonly found in cattle, sheep, goats and other domestic mammals. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
Q fever
R
S
T
U
V
W
X
Y
Z
Medicines

The infection results from inhalation of contaminated particles of the inhaled air. The incubation time is 9-40 days. It is considered possibly the most infectious disease in the world, as a human being can be infected by a single bacterium.

History

It was first described by Edward Holbroock Derrick in abattoir workers in Brisbane, Queensland, Australia as a disease of unknown origin and therefore “query fever”. In 1937 the bacterium was isolated by Frank MacFarlane Burnet and Freeman from one of Derrick’s patients for the first time and identified as Rickettsia-species. H.R. Cox and Davis isolated the pathogen from ticks in Montana, USA in 1938, described the transmission and it was officially named Coxiella burnetii the same year. Meanwhile Coxiella burnetii is no longer regarded as closely related to Rickettsiae.

Manifestations

The most common manifestation is flu-like symptoms with abrupt onset of fever, malaise, severe headache, myalgia (muscle pain), loss of appetite, dry cough, pleuritic pain, chills, confusion and gastro-intestinal symptoms such as nausea, vomiting and diarrhoea. The fever lasts approximately 7-14 days.

During the course, the disease can progress to an atypical pneumonia, which often results in a life threatening acute respiratory distress syndrome (ARDS), whereby such symptoms usually occur during the first 4-5 days of infection.

Less often the Q fever causes (granulomatous) hepatitis which becomes symptomatic with malaise, fever, liver enlargement (hepatomegaly), pain in the right upper quadrant of the abdomen and jaundice (icterus).

The chronic form of the Q fever is virtually identical with the inflammation of the inner lining of the heart (endocarditis), which can occur after months or decades following the infection. It is usually deadly if untreated. However, with appropriate treatment this lethality is around 10%.

Appearance and incidence

The pathogenic agent is to be found everywhere except Antarctica and New Zealand. In Europe it rather appears as hepatitis and rather as pneumonia in the United States. The bacterium is extremely sustainable and infectious: a single one is able to cause an infection. The common way of infection is inhalation of contaminated dust, contact with contaminated milk, meat, wool and particularly birthing products. Ticks can transfer the pathogenic agent to other animals. Transfer between humans seems extremely rare and has so far been described in very few cases.

Men are slightly more often affected than women, what most likely is attributed to exposition in typical professions such as livestock breeding, dairy and meat production. A vaccination exists and its use is recommended to exposed people in some countries.

Read more at Wikipedia.org


[List your site here Free!]


Q fever and the US military
From Emerging Infectious Diseases, 8/1/05 by Alicia D. Anderson

To the Editor: Q fever is a zoonotic disease caused by the rickettsialike organism Coxiella burnetii. The disease has a worldwide distribution and can infect many different species, although cattle, sheep, and goats are the primary reservoirs (1). Transmission to humans usually occurs by inhaling dust or aerosols from infected animals, and approximately half of infected persons manifest clinical symptoms. In acute Q fever infection, the 3 main sets of symptoms are flulike syndrome, pneumonia, and hepatitis (2,3).

Q fever has military relevance not only in its potential use as a bioterrorism agent, but also because of the risk for natural infection in deployed military personnel. Thousands of cases of Q fever have been seen in military personnel since the disease was first reported in the 1930s (4). Since the most common mode of transmission is airborne, personnel do not need to have direct contact with infected animals to be exposed.

C. burnetii was first recognized as an infectious disease threat to US military troops serving in Iraq in 2003 during a pneumonia outbreak investigation. Nineteen cases of severe pneumonia, including 2 deaths, occurred from March 1 to August 20 (5). A case was defined as occurring in a patient with bilateral alveolar infiltrates that required intubation and mechanical ventilation. This investigation involved extensive serologic testing for possible infectious causes of pneumonia, including C. burnetii. Of 19 patients with severe pneumonia tested for C. burnetii, 3 had positive antibody titers by immunofluorescence assay (IFA). No other infectious cause was confirmed for the remaining cases of pneumonia. Although C. burnetii was not determined to be the cause of the pneumonia outbreak, the finding of 3 patients with positive antibody titers launched an effort to ascertain other cases of Q fever among military personnel who served in Iraq during that time.

Approximately 62 cases of pneumonia, both severe and nonsevere, occurred in Iraq from March 1 to August 20, 2003. A pneumonia case was defined as occurring in a patient with a chest radiograph suggesting pneumonia and [greater than or equal to] 1 of the following symptoms: fever, cough, or shortness of breath. The Defense Medical Surveillance System (DMSS) was queried to determine how many patients had both predeployment and postdeployment serum samples available for Q fever testing. The Army Medical Surveillance Activity, which operates DMSS, also maintains the Department of Defense Serum Repository and stores serum from service members after mandatory HIV testing and deployment processing (6). Predeployment sera must be collected within the year before deployment.

Twenty-two soldiers had predeployment and postdeployment sera available; samples were tested for phase I and phase II antibody to Q fever by using IFA. Results showed 5 additional soldiers in whom pneumonia was diagnosed while serving in Iraq and who seroconverted to C. burnetii before postdeployment serum draws (Table). All predeployment antibody titers for both immunoglobulin (Ig) G and IgM were negative in these 5 soldiers, with an IFA titer of 1:16 as a cutoff.

The initial 3 Q fever patients ascertained through the pneumonia outbreak investigation were extensively interviewed for possible exposures. All 3 patients first experienced symptoms while in northern Iraq and reported contact with domestic animals, including dogs, cats, sheep, goats, and camels. Two of the patients reported tick bites within 30 days before becoming ill, and 1 reported drinking raw sheep's milk. The 5 other patients who became ill with pneumonia also first sought care while in northern Iraq. Predeployment sera from these 3 patients were also tested for C. burnetii by IFA, and all samples were negative for both IgG and IgM.

Extremely limited information is available on Q fever disease prevalence in Iraq, either in animals or humans. Iraq is primarily an agricultural country, and nomadic herding takes place countrywide, except in the northernmost regions and along the eastern border, where adequate land is available for grazing livestock. The most common livestock in Iraq are cattle, sheep, and goats (7). Although herds of infected animals may exist in any region of Iraq, larger concentrations of livestock may exist in northern areas, where land is suitable for ruminants to graze. This concentration could lead to a higher risk for transmission to humans because the chance of contact with infected animals would be greater.

These data indicate the potential importance of C. burnetii as an infectious disease threat to US military troops in Iraq. Healthcare providers should include Q fever in their differential diagnosis of community-acquired pneumonia and consider adding doxycycline to a combined antimicrobial drug regimen to presumptively treat severe pneumonia. Future studies to be completed include case ascertainment to locate US troops who were infected with Q fever while in Iraq and in whom pneumonia or other clinical manifestations of illness may have developed.

Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 1996 edition.

References

(1.) McQuiston JH, Childs JE. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2002:2: 179-91.

(2.) Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999;12:518-53.

(3). Stoker MGR Marmiou BP. The spread of Q fever from animals to man: the natural history of a rickettsial disease. Bull World Health Organ. 1955;13:781-806.

(4.) Spicer AJ. Military significance of Q fever: a review. J R Soc Med. 1978;71:762-7.

(5.) Severe acute pneumonitis among deployed U.S. military personnel--southwest Asia, March-August, 2003. MMWR Morb Mortal Wkly Rep. 2003:52:857.

(6.) Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92:1900-4.

(7.) Bishay FK. Towards sustainable agricultural development in Iraq: the transition from relief, rehabilitation, and reconstruction to development [monograph on the Internet]. Rome: Food and Agriculture Organization of the United Nations. 21103 [cited 2005 Jun 2]. Available from http://www.fao.org/documents/show_cdr.asp?url_file=/DOCREP/ 006/Y9870E/Y9870E00.HTM

Alicia D. Anderson, * Bonnie Smoak, * Eric Shuping, ([dagger]) Christopher Ockenhouse, * and Bruno Petruccelli ([dagger])

* Walter Reed Army Institute of Research, Silver Spring, Maryland, USA; ([dagger]) Ireland Army Community Hospital, Fort Knox, Kentucky, USA; and ([double dagger]) US Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, Maryland, USA

Address for correspondence: Alicia D. Anderson, Walter Reed Army Institute of Research, Preventive Medicine Division, 503 Robert Grant Ave, Silver Spring, MD 20910, USA; fax: 301-319-9104; email: alicia.anderson1@us.army.mil

COPYRIGHT 2005 U.S. National Center for Infectious Diseases
COPYRIGHT 2005 Gale Group

Return to Q fever
Home Contact Resources Exchange Links ebay